Technical Analysis for MDP - Medexus Pharmaceuticals Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.600 | -1.23% | -0.020 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
50 DMA Resistance | Bearish | -1.23% | |
Outside Day | Range Expansion | -1.23% | |
Oversold Stochastic | Weakness | -1.23% | |
50 DMA Resistance | Bearish | -0.62% | |
Stochastic Buy Signal | Bullish | -0.62% | |
NR7 | Range Contraction | -0.62% |
Get a Trading Sidekick!
- Earnings date: 2024-02-01
Medexus Pharmaceuticals Inc. Description
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Classification
Keywords: Health Infrastructure Healthcare Pharma Pipe Pharmaceutical Integrated Pipeline Disease Drugs Pharmaceuticals Diseases Arthritis Medication Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China Rheumatoid Arthritis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.53 |
52 Week Low | 1.12 |
Average Volume | 43,594 |
200-Day Moving Average | 2.180 |
50-Day Moving Average | 1.642 |
20-Day Moving Average | 1.721 |
10-Day Moving Average | 1.661 |
Average True Range | 0.109 |
RSI (14) | 42.86 |
ADX | 15.89 |
+DI | 15.714 |
-DI | 18.826 |
Chandelier Exit (Long, 3 ATRs) | 1.675 |
Chandelier Exit (Short, 3 ATRs) | 1.796 |
Upper Bollinger Bands | 1.920 |
Lower Bollinger Band | 1.522 |
Percent B (%b) | 0.2 |
BandWidth | 23.161 |
MACD Line | -0.017 |
MACD Signal Line | 0.003 |
MACD Histogram | -0.0199 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.660 | ||||
Resistance 3 (R3) | 1.667 | 1.653 | 1.650 | ||
Resistance 2 (R2) | 1.653 | 1.638 | 1.650 | 1.647 | |
Resistance 1 (R1) | 1.627 | 1.629 | 1.620 | 1.620 | 1.643 |
Pivot Point | 1.613 | 1.613 | 1.610 | 1.610 | 1.613 |
Support 1 (S1) | 1.587 | 1.598 | 1.580 | 1.580 | 1.557 |
Support 2 (S2) | 1.573 | 1.589 | 1.570 | 1.553 | |
Support 3 (S3) | 1.547 | 1.573 | 1.550 | ||
Support 4 (S4) | 1.540 |